Generation of human induced pluripotent stem cell line from a patient with a long QT syndrome type 2

Stem Cell Res. 2016 Mar;16(2):304-7. doi: 10.1016/j.scr.2015.12.039. Epub 2016 Jan 6.

Abstract

We report here the generation of human iPS cell line UKKi009-A from dermal fibroblasts of a patient carrying heterozygous mutation c.3035-3045delTCCCTCGATGC, p.Leu1012Pro (fs*55) in KCNH2 gene leading to long QT syndrome type 2 (LQT2). We used the Sleeping Beauty transposon-based plasmids expressing OSKM along with microRNAs 307/367 to reprogram the fibroblasts. The iPS cells possess pluripotent stem cell characteristics and differentiate to cell lineages of all three germ layers. This cell line can serve as a source for in vitro modeling of LQT2. This cell line is distributed by the European Collection of Authenticated Cell Cultures (ECACC).

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Base Sequence
  • Cell Differentiation
  • Cells, Cultured
  • Cellular Reprogramming
  • Comparative Genomic Hybridization
  • ERG1 Potassium Channel / genetics
  • Female
  • Fibroblasts / cytology
  • Flow Cytometry
  • Genotype
  • Heterozygote
  • Humans
  • Induced Pluripotent Stem Cells / cytology*
  • Induced Pluripotent Stem Cells / metabolism
  • Karyotype
  • Long QT Syndrome / genetics
  • Long QT Syndrome / pathology*
  • Microscopy, Fluorescence
  • Polymorphism, Single Nucleotide
  • Real-Time Polymerase Chain Reaction
  • Skin / cytology
  • Transcription Factors / genetics
  • Transcription Factors / metabolism

Substances

  • ERG1 Potassium Channel
  • KCNH2 protein, human
  • Transcription Factors